125 related articles for article (PubMed ID: 17621271)
1. POU2AF1, an amplification target at 11q23, promotes growth of multiple myeloma cells by directly regulating expression of a B-cell maturation factor, TNFRSF17.
Zhao C; Inoue J; Imoto I; Otsuki T; Iida S; Ueda R; Inazawa J
Oncogene; 2008 Jan; 27(1):63-75. PubMed ID: 17621271
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 11q23.1 is an unstable region in B-cell tumor cell lines.
Poretti G; Kwee I; Bernasconi B; Rancoita PM; Rinaldi A; Capella C; Zucca E; Neri A; Tibiletti MG; Bertoni F
Leuk Res; 2011 Jun; 35(6):808-13. PubMed ID: 21420167
[TBL] [Abstract][Full Text] [Related]
3. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
[TBL] [Abstract][Full Text] [Related]
4. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
[TBL] [Abstract][Full Text] [Related]
5. Identification of PAK4 as a putative target gene for amplification within 19q13.12-q13.2 in oral squamous-cell carcinoma.
Begum A; Imoto I; Kozaki K; Tsuda H; Suzuki E; Amagasa T; Inazawa J
Cancer Sci; 2009 Oct; 100(10):1908-16. PubMed ID: 19594544
[TBL] [Abstract][Full Text] [Related]
6. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
[TBL] [Abstract][Full Text] [Related]
7. beta-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model.
Ashihara E; Kawata E; Nakagawa Y; Shimazaski C; Kuroda J; Taniguchi K; Uchiyama H; Tanaka R; Yokota A; Takeuchi M; Kamitsuji Y; Inaba T; Taniwaki M; Kimura S; Maekawa T
Clin Cancer Res; 2009 Apr; 15(8):2731-8. PubMed ID: 19351774
[TBL] [Abstract][Full Text] [Related]
8. Identification of a potential role for POU2AF1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.
Auer RL; Starczynski J; McElwaine S; Bertoni F; Newland AC; Fegan CD; Cotter FE
Genes Chromosomes Cancer; 2005 May; 43(1):1-10. PubMed ID: 15672409
[TBL] [Abstract][Full Text] [Related]
9. Molecular and biological characterization of three novel interleukin-6-dependent human myeloma cell lines.
Verdelli D; Mattioli M; Fabris S; Nobili L; Intini D; Guerneri S; Todoerti K; Zanella A; Deliliers GL; Lombardi L; Neri A
Haematologica; 2005 Nov; 90(11):1541-8. PubMed ID: 16266902
[TBL] [Abstract][Full Text] [Related]
10. E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer.
Oeggerli M; Schraml P; Ruiz C; Bloch M; Novotny H; Mirlacher M; Sauter G; Simon R
Oncogene; 2006 Oct; 25(49):6538-43. PubMed ID: 16953223
[TBL] [Abstract][Full Text] [Related]
11. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
[TBL] [Abstract][Full Text] [Related]
12. Molecular and transcriptional characterization of the novel 17p11.2-p12 amplicon in multiple myeloma.
Fabris S; Todoerti K; Mosca L; Agnelli L; Intini D; Lionetti M; Guerneri S; Lambertenghi-Deliliers G; Bertoni F; Neri A
Genes Chromosomes Cancer; 2007 Dec; 46(12):1109-18. PubMed ID: 17823926
[TBL] [Abstract][Full Text] [Related]
13. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibition of proteasome and silencing by vascular endothelial cell growth factor-specific siRNA induce additive antitumor activity in multiple myeloma.
Koldehoff M; Beelen DW; Elmaagacli AH
J Leukoc Biol; 2008 Aug; 84(2):561-76. PubMed ID: 18458152
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the c-myc and the pvt-like region in human multiple myeloma.
Bakkus MH; Brakel-van Peer KM; Michiels JJ; van 't Veer MB; Benner R
Oncogene; 1990 Sep; 5(9):1359-64. PubMed ID: 2216459
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth.
Darwish H; Cho JM; Loignon M; Alaoui-Jamali MA
Oncogene; 2007 Jun; 26(29):4319-28. PubMed ID: 17260023
[TBL] [Abstract][Full Text] [Related]
19. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer.
Medina PP; Castillo SD; Blanco S; Sanz-Garcia M; Largo C; Alvarez S; Yokota J; Gonzalez-Neira A; Benitez J; Clevers HC; Cigudosa JC; Lazo PA; Sanchez-Cespedes M
Hum Mol Genet; 2009 Apr; 18(7):1343-52. PubMed ID: 19153074
[TBL] [Abstract][Full Text] [Related]
20. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
Sun G; Zhou J; Yin A; Ding Y; Zhong M
Int J Oncol; 2008 May; 32(5):1065-71. PubMed ID: 18425333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
